Literature DB >> 20673913

Toward discerning the mechanisms of atrial fibrillation from surface electrocardiogram and spectral analysis.

Omer Berenfeld1.   

Abstract

Atrial fibrillation (AF) is the main cause of stroke and the most common sustained arrhythmia, afflicting about 2.3 million Americans. Clinical treatment and management of AF would benefit from a noninvasive and global assessment of the arrhythmia; however, that avenue seems currently limited in part by our poor understanding of arrhythmia itself. Experimental studies of AF in the isolated sheep heart demonstrated that high-frequency sources in the posterior wall of the left atrium drive the fibrillatory activity throughout both atria. Motivated by those results and by a growing body of work investigating how measurements of the cycle length of activity in patients during AF can contribute to its treatment, we focused our analysis on the dispersion of dominant frequency (DF) of the activity during AF in humans. Using electroanatomic mapping and Fourier methods, we generated 3-dimensional intracardiac DF maps of the atria in patients before AF ablation procedures and identified relatively small high-DF (HDF) sites. In patients with paroxysmal AF, the HDF sites are often localized to the posterior left atrium near the ostia of the pulmonary veins. In contrast, patients with permanent AF demonstrate HDF sites that are more often localized to the atria than the posterior left atrium-pulmonary vein junction. In our study, ablation at HDF sites resulted in significant slowing of the arrhythmia and termination of sustained AF in 87% of patients with paroxysmal AF. Furthermore, we found that abolishing, by ablation, preexisting left atrium to right atrium DF gradients predicted long-term freedom of AF in both paroxysmal and persistent AF patients. Overall, the analysis of intracardiac electrical recordings in the frequency domain has greatly enhanced our understanding of its underlying mechanisms and may contribute to monitoring drug effects and guide ablation procedures aiming at its termination. On the other hand, current body surface mapping methods have also suggested better correlations between surface AF frequency and intracardiac local DFs as compared with spatiotemporal activation patterns. Therefore, further study of the correlation of spectral observables obtained from the atria and from the surface electrocardiogram during AF seems to have the potential to advance our ability to diagnose and discern mechanisms of AF noninvasively.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20673913      PMCID: PMC2995994          DOI: 10.1016/j.jelectrocard.2010.06.005

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  49 in total

1.  Structure of canine Bachmann's bundle related to propagation of excitation.

Authors:  P C Dolber; M S Spach
Journal:  Am J Physiol       Date:  1989-11

2.  Simultaneous multisite mapping studies during induced atrial fibrillation in the sterile pericarditis model. Insights into the mechanism of its maintenance.

Authors:  K Kumagai; C Khrestian; A L Waldo
Journal:  Circulation       Date:  1997-01-21       Impact factor: 29.690

3.  Cholinergic atrial fibrillation: I(K,ACh) gradients determine unequal left/right atrial frequencies and rotor dynamics.

Authors:  Farzad Sarmast; Arun Kolli; Alexey Zaitsev; Keely Parisian; Amit S Dhamoon; Prabal K Guha; Mark Warren; Justus M B Anumonwo; Steven M Taffet; Omer Berenfeld; José Jalife
Journal:  Cardiovasc Res       Date:  2003-10-01       Impact factor: 10.787

Review 4.  Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes.

Authors:  L Belardinelli; J C Shryock; Y Song; D Wang; M Srinivas
Journal:  FASEB J       Date:  1995-03       Impact factor: 5.191

5.  Atrial activation during chronic atrial fibrillation in patients with isolated mitral valve disease.

Authors:  A Harada; K Sasaki; T Fukushima; M Ikeshita; T Asano; S Yamauchi; S Tanaka; T Shoji
Journal:  Ann Thorac Surg       Date:  1996-01       Impact factor: 4.330

6.  Changes in atrial fibrillation cycle length and inducibility during catheter ablation and their relation to outcome.

Authors:  Michel Haïssaguerre; Prashanthan Sanders; Mélèze Hocini; Li-Fern Hsu; Dipen C Shah; Christophe Scavée; Yoshihide Takahashi; Martin Rotter; Jean-Luc Pasquié; Stéphane Garrigue; Jacques Clémenty; Pierre Jaïs
Journal:  Circulation       Date:  2004-06-07       Impact factor: 29.690

7.  Quantitative assessment of the spatial organization of atrial fibrillation in the intact human heart.

Authors:  G W Botteron; J M Smith
Journal:  Circulation       Date:  1996-02-01       Impact factor: 29.690

8.  Effects of adenosine on atrial refractoriness and arrhythmias.

Authors:  G Kabell; L V Buchanan; J K Gibson; L Belardinelli
Journal:  Cardiovasc Res       Date:  1994-09       Impact factor: 10.787

9.  Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation.

Authors:  C A Morillo; G J Klein; D L Jones; C M Guiraudon
Journal:  Circulation       Date:  1995-03-01       Impact factor: 29.690

10.  Intra-atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation.

Authors:  Jérôme Kalifa; José Jalife; Alexey V Zaitsev; Suveer Bagwe; Mark Warren; Javier Moreno; Omer Berenfeld; Stanley Nattel
Journal:  Circulation       Date:  2003-08-04       Impact factor: 29.690

View more
  2 in total

1.  Frontiers in Non-invasive Cardiac Mapping: Rotors in Atrial Fibrillation-Body Surface Frequency-Phase Mapping.

Authors:  Felipe Atienza; Andreu M Climent; María S Guillem; Omer Berenfeld
Journal:  Card Electrophysiol Clin       Date:  2015-03-01

Review 2.  Frontiers in noninvasive cardiac mapping rotors in atrial fibrillation-body surface frequency-phase mapping.

Authors:  Felipe Atienza; Andreu M Climent; María S Guillem; Omer Berenfeld
Journal:  Card Electrophysiol Clin       Date:  2015-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.